Juno Therapeutics, Inc., A Bristol-myers Squibb Company

This trial aimed to see if a one-time CAR-T cell therapy (liso-cel) worked better and was safer than standard chemotherapy for adults whose follicular lymphoma had returned or stopped responding to prior treatments. It was a large, global Phase 3 study that would have randomly as…